Boyce Sarah
Transaction: 06/26/2026
BUY
Change
+19,000
Price
$14.19
Filing
06/26/2026
Type
BUY
Contineum Therapeutics, Inc.
CTNM • Biotechnology
$16.70
▼ -0.87 (-4.95%)
Current price
EarningsLatest report: Mar 31, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$530.51M
Growth
—
Cash Flow
1/5
Trend
Volatile
Evidence
Manageable debt level · 0.03Healthy liquidity · 27.5Weak profitability
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: May 5, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:36 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$16.70
Change-4.95%
Market Cap$530.51M
52W Range3.72 - 16.33
Beta0.89
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.03
Current Ratio27.50
Quick Ratio27.50
Target$16.00
Price$16.70
Change-4.95%
Market Cap$530.51M
52W Range3.72 - 16.33
Beta0.89
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.03
Current Ratio27.50
Quick Ratio27.50
Target$16.00
Target Upside-4.19%
Target Median$16.00
Target Range16.00 - 16.00
Volume3.89M
Avg Volume292.13K
EPS Surprise0.16
Investment DNA
How strong this company looks for long-term investors
51
out of 100
Business Quality
Margins, moat, returns
27/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
93/100
Why this score▼
Manageable debt level · 0.03Healthy liquidity · 27.5Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-06-29
Low
$16.00
Mean
$16.00
Median
$16.00
High
$16.00
Insider Transactions
Recent executive and insider activity
Brady Todd R.
Transaction: 06/26/2026
BUY
Change
+19,000
Price
$14.19
Filing
06/26/2026
Type
BUY
Ignelzi Troy A.
Transaction: 06/26/2026
BUY
Change
+19,000
Price
$14.19
Filing
06/26/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Boyce Sarah | BUY | +19,000 | $14.19 | 06/26/2026 | 06/26/2026 |
| Brady Todd R. | BUY | +19,000 | $14.19 | 06/26/2026 | 06/26/2026 |
| Ignelzi Troy A. | BUY | +19,000 | $14.19 | 06/26/2026 | 06/26/2026 |
| Schimmelpennink Evert B. | BUY | +19,000 | $14.19 | 06/26/2026 | 06/26/2026 |
| Ware Olivia C | BUY | +19,000 | $14.19 | 06/26/2026 | 06/26/2026 |
| Lyons-Williams Lori | BUY | +19,000 | $14.19 | 06/26/2026 | 06/26/2026 |
| Miralles Gines Diego | BUY | +19,000 | $14.19 | 06/26/2026 | 06/26/2026 |
| Lorrain Daniel S. | SELL | -4,170 | $13.16 | 06/01/2026 | 06/01/2026 |
| Lorrain Daniel S. | SELL | -300 | $13.84 | 05/01/2026 | 05/01/2026 |
| Lorrain Daniel S. | SELL | -4,170 | $13.43 | 04/06/2026 | 04/06/2026 |
| Watkins Tim | SELL | -3,611 | $15.02 | 03/02/2026 | 03/02/2026 |
| Watkins Tim | SELL | -3,611 | $4.50 | 03/02/2026 | 03/02/2026 |
| Lorrain Daniel S. | SELL | -4,170 | $15.01 | 03/02/2026 | 03/02/2026 |
| Lorrain Daniel S. | SELL | -3,824 | $1.01 | 02/25/2026 | 02/26/2026 |
| Lorrain Daniel S. | SELL | -3,824 | $16.01 | 02/25/2026 | 02/26/2026 |
| Stengone Carmine N. | SELL | -2,700 | $16.02 | 02/25/2026 | 02/26/2026 |
| Stengone Carmine N. | SELL | -2,700 | $1.26 | 02/25/2026 | 02/26/2026 |
| Lorrain Daniel S. | SELL | -4,300 | $1.01 | 02/24/2026 | 02/26/2026 |
| Lorrain Daniel S. | SELL | -4,300 | $16.03 | 02/24/2026 | 02/26/2026 |
| Stengone Carmine N. | SELL | -4,400 | $16.02 | 02/24/2026 | 02/26/2026 |